George A. Scangos

CIK: 0001202102

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (18.2%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (45.5%)

Compensation grants

Other (G, F, J, C, D, …)4 (36.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

VYGR

Voyager Therapeutics, Inc.

Director

AGILENT TECHNOLOGIES, INC.

Director

VIR

Vir Biotechnology, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (11 total)

VYGR
Voyager Therapeutics, Inc.
Jun 9, 2026
Award(A)
Stock Option (Right to Buy)
Direct
30K shares-
A
AGILENT TECHNOLOGIES, INC.
Mar 19, 2026
Award(A)
Direct
2.2K shares at avg. $111.75$241K
A
AGILENT TECHNOLOGIES, INC.
Mar 19, 2026
Award(A)
Direct
1.1K shares at avg. $111.75$118K
VYGR
Voyager Therapeutics, Inc.
Jun 3, 2025
Award(A)
Stock Option (Right to Buy)
Direct
24K shares-
A
AGILENT TECHNOLOGIES, INC.
Mar 14, 2025
Award(A)
Direct
1.8K shares at avg. $121.18$220K
VIR
Vir Biotechnology, Inc.
Feb 24, 2025
Sale(S)
Direct
10.1K shares at avg. $9.45$95K
VIR
Vir Biotechnology, Inc.
Feb 18, 2025
Sale(S)
Direct
11K shares at avg. $9.81$108K
VIR
Vir Biotechnology, Inc.
Oct 23, 2024
Other(J)
Direct
598.3K shares-
VIR
Vir Biotechnology, Inc.
Oct 23, 2024
Other(J)
Indirect
598.3K shares-
VIR
Vir Biotechnology, Inc.
Oct 23, 2024
Other(J)
Indirect
598.3K shares-
VIR
Vir Biotechnology, Inc.
Oct 23, 2024
Other(J)
Indirect
598.3K shares-

		Type	Shares	Price		Ownership
Jun 9, 2026	VYGR Voyager Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	30,000	-	-	Direct
Mar 19, 2026	A AGILENT TECHNOLOGIES, INC.	Award(A)	2,158	$111.75	$241,157	Direct
Mar 19, 2026	A AGILENT TECHNOLOGIES, INC.	Award(A)	1,057	$111.75	$118,120	Direct
Jun 3, 2025	VYGR Voyager Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	24,000	-	-	Direct
Mar 14, 2025	A AGILENT TECHNOLOGIES, INC.	Award(A)	1,819	$121.18	$220,426	Direct
Feb 24, 2025	VIR Vir Biotechnology, Inc.	Sale(S)	10,056	$9.45	$95,063	Direct
Feb 18, 2025	VIR Vir Biotechnology, Inc.	Sale(S)	10,964	$9.81	$107,575	Direct
Oct 23, 2024	VIR Vir Biotechnology, Inc.	Other(J)	598,270	-	$0	Direct
Oct 23, 2024	VIR Vir Biotechnology, Inc.	Other(J)	598,270	-	$0	Indirect
Oct 23, 2024	VIR Vir Biotechnology, Inc.	Other(J)	598,270	-	$0	Indirect
Oct 23, 2024	VIR Vir Biotechnology, Inc.	Other(J)	598,270	-	$0	Indirect

1-11 of 11 transactions

About SCANGOS GEORGE A

SCANGOS GEORGE A (SEC CIK 0001202102) files insider reports with the SEC as Director of Voyager Therapeutics, Inc. (VYGR), Director of AGILENT TECHNOLOGIES, INC. (A) and Director of Vir Biotechnology, Inc. (VIR).

Signal8 holds 7 ownership filings by SCANGOS GEORGE A, all Form 4s, filed between Oct 24, 2024 and Jun 11, 2026. Those filings report 11 transactions, from Oct 23, 2024 to Jun 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on SCANGOS GEORGE A's filings is in LEXINGTON, MA.

Recent filings by SCANGOS GEORGE A

Jun 9, 2026: Grant or award of VYGR derivative securities (Form 4, code A).
Mar 19, 2026: Grants or awards of A shares (2 lines, Form 4, code A).
Jun 3, 2025: Grant or award of VYGR derivative securities (Form 4, code A).
Mar 14, 2025: Grant or award of A shares (Form 4, code A).
Feb 24, 2025: Open-market sale of VIR shares (Form 4, code S).

Other insiders filing for Voyager Therapeutics, Inc. (VYGR)

MACKEY CATHERINE J, Director
Hyman Steven, Director
Vitale Nancy, Director
Higgins Michael J, Director
Onyia Jude, Director
GERAGHTY JAMES A, Director

How to read Form 4 transaction codes